Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Nuclear medicine

Article Abstract:

Specialists in nuclear medicine have developed many chemicals that can be used to image various parts of the body. The most intensive use of these chemicals is in patients with heart attacks. The chemicals can be injected and then imaging instruments can measure the amount of blood perfusing through the heart. Similar techniques can be used in cancer patients to image tumors. Surgeons can use handheld detectors to help them identify areas that contain the tumor. Positron emission tomography (PET) using labelled glucose can also identify malignant tumors.

Author: Siegel, Barry A., Royal, Henry D.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Research, Heart, Cancer, Nuclear medicine, Radiopharmaceuticals

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Radiation Exposure From Outpatient Radioactive Iodine ([I.sup.131]) Therapy for Thyroid Carcinoma

Article Abstract:

Many patients who take radioactive iodine for thyroid diseases can be treated on an outpatient basis. Because the iodine is radioactive, the US Nuclear Regulatory Commission (NRC) required all patients receiving certain dosages to be treated in hospitals to limit family members' exposure to the radiation. However, the agency revised this regulation in May, 1997. Researchers measured household levels of radiation in the homes of 30 patients taking radioactive iodine. All homes had radiation levels well below the level mandated by the NRC.

Author: Grigsby, Perry W., Siegel, Barry A., Baker, Susan, Eichling, John O.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Health aspects, Laws, regulations and rules, Iodine, Iodine (Chemical element), Radiation, Background, Ambulatory medical care, Background radiation, Ambulatory care

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma

Article Abstract:

The application of the positron emission tomography (PET) in the posttherapy analysis of patients with cervical carcinoma is discussed. The study shows that patients have a high chance of survival if given a 3-month posttherapy of PET with F-18 fluorodeoxyglucose (FDG).

Author: Grigsby, Perry W., Siegel, Barry A., Schwarz, Julie K., Dehdashti, Farrokh
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
United States, Care and treatment, Cervical cancer, Technology application, Papillomavirus infections, PET imaging, Positron emission tomography, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: Chemoprevention of hereditary ovarian cancer. Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study
  • Abstracts: Successful conservative management of primary nonmetastatic cervical choriocarcinoma. Transvaginal ultrasonography at early pregnancy cannot be used alone for targeted organ ultrasonographic examination in a high-risk population
  • Abstracts: Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome
  • Abstracts: Evans' syndrome associated with dermatomyositis. Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis
  • Abstracts: Know how. Silver dressings: Absorption and antibacterial efficacy. When and how to use adhesive film dressings
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.